Onyx Pharma (ONXX) Reaches Agreement with FDA on SPA for Phase 3 Trial of Carfilzomib
Tweet Send to a Friend
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the company reached agreement with
the U.S. FDA on a Special Protocol ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
the U.S. FDA on a Special Protocol ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
